###### Strengths and limitations of this study

-   To the best of our knowledge, this will be the first systematic review examining if abductor muscle strength deficit is present in patients after total hip arthroplasty performed for osteoarthritis.

-   The homogeneity of the measurement methods described in the inclusion criteria (no hand-held manometers, isometric measurements only in an abduction angle of 0°) allows the extraction of directly comparable data, suitable for a meta-analysis.

-   This review will likely identify factors influencing the abductor strength deficit, hence assisting the choice of the correct surgical methods or rehabilitation protocols.

-   A possible limitation is the inclusion of studies only in English or German language.

Introduction {#s1}
============

Osteoarthritis (OA) of the hip is a common degenerative disorder. Despite its high prevalence, to date there is no cure for OA, and the ultimate treatment for severe OA is total hip arthroplasty (THA).[@R1] Overall, the results of THA appear to be very satisfying with more than 90% of THA patients reporting a good to excellent result.[@R2] However, patients after THA have been reported to have strength deficits.[@R3] These deficits have been described in patients with OA and reported to increase as the disease progresses and persist for a longer time after THA treatment.[@R4] One of the most common strength deficits is that of the abductor muscle group.[@R4]Abductor muscle group deficit after THA can be described compared with a control group of healthy individuals[@R6] or comparing the affected hip with the contralateral side in case of unilateral THA.[@R7]

The abductor muscle group mainly consist of the primary hip abductors gluteus medius, gluteus minimus and tensor fasciae latae muscles. Secondary hip abductors include the piriformis, sartorius and rectus femoris muscles.[@R8] The abductor muscle group abducts the hip and stabilises the pelvis, maintaining the level of contralateral pelvis and preventing hip adduction during single leg stance.[@R9] Furthermore, the gluteus medius and minimus have a secondary role in hip rotation.[@R8]

Damage of the abductor mechanism results in drop of the contralateral pelvis during single leg stance clinically manifested as a Trendelenburg gait.[@R11] Furthermore, abductor muscle strength deficit has been linked to knee OA,[@R5] patellofemoral pain syndrome[@R13] and chronic lower back pain.[@R14] Especially for the elderly population, loss of abduction function can compromise balance and increase the risk of falls.[@R15] Specifically for THA, abductor muscle function has been shown to be directly associated with physical function[@R5] and important in limiting limping.[@R16] Overall, conservation of the abduction muscle strength is important not only for an optimal outcome of THA but also to prevent pain because of other orthopaedic conditions linked to abductor strength deficits.

Many studies have tried to explore and quantify a potential abductor muscle strength deficit after THA as well as identify possible causes and treatment options.[@R4] Furthermore, surgical approaches avoiding any damage to the abductor mechanism have been established[@R18] and rehabilitation programmes have been developed to prevent or reduce this strength deficit.[@R17] However, results reported in the literature are controversial, and the factors influencing abductor muscle strength deficit after THA are poorly understood.

The aim of this protocol study was to present an objective and transparent methodology to conduct a systematic review and meta-analysis aimed to increase knowledge regarding the magnitude of abductor muscle strength deficits after THA and to depict, as well as to provide understanding of the associations to external between factors including patient characteristics, surgical methods and rehabilitation programmes and abductor muscle strength deficit after THA and study characteristics

Methods and analyses {#s2}
====================

This protocol is reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guideline.[@R21] The initial preliminary search was conducted on 5 May 2019. The study was submitted for registration in PROSPERO on 2 October 2019 and registered on 26 February 2020. The anticipated completion date is 30 June 2020. The research question was formulated according to the Population, Intervention, Comparison, Outcome, Study design tool ([table 1](#T1){ref-type="table"}).[@R22]

###### 

The Population, Intervention, Comparison, Outcome, Study design process

  ------------------------------------------------------------------------------------------------------------------------------------------------
  Item                                                     Specification
  -------------------------------------------------------- ---------------------------------------------------------------------------------------
  Population, or participants and conditions of interest   Patients with OA of the hip (any age, any gender and any severity)

  Interventions or exposures                               Total hip arthroplasty

  Comparisons or control groups                            For comparison between limps of the same subject: asymptomatic contralateral hip\
                                                           For comparison between patients and heathy individuals: asymptomatic control subjects

  Outcomes of interest                                     Muscle strength of hip abductors

  Study designs                                            Any study design, only published studies, no conference abstracts
  ------------------------------------------------------------------------------------------------------------------------------------------------

OA, osteoarthritis.

Eligibility criteria {#s2-1}
--------------------

### Inclusion criteria {#s2-1-1}

Human-based clinical studies reporting on abductor muscle strength after THA performed for OA of the hip will be considered for inclusion. No restriction will be placed on study design, publication date, operative approach, prosthesis design, age and sex of the patients or severity of OA

### Exclusion Criteria {#s2-1-2}

Studies published in a language other than English or German as well as studies not reporting absolute muscle strength values or torque ratios will be excluded. Studies reporting on hip abductor strength measured manually or at an abduction angle other than 0° will not be considered for this review.

### Methodological considerations {#s2-1-3}

Studies reporting on hip abductor strength measured manually (with a hand-held manometer or without a manometer) will not be considered because the results are not reliable and not directly comparable with studies using electronic dynamometers. In addition, studies reporting on isometric abductor muscle strength at an abduction angle other than 0° will not be included because torque measurement at other angles cannot be compared with those conducted in 0° abduction and does not reflect the relevant muscle strength during walking and standing.

Information sources and search strategy {#s2-2}
---------------------------------------

Text words (synonyms and word variations) and database-specific subject headings for hip OA, total hip replacement and postoperative performance will be used. We will search the electronic databases Embase via embase.com, Medline ALL via Ovid, and the Cochrane Central Register of Controlled Trials. No language or date restrictions will be applied. All retrieved references will be exported to Endnote V.X9 and deduplicated. To identify possible additional studies that will escape our electronic database searches, the bibliographic references of all included articles as well as the citations of those that are indexed in Scopus or the Web of Science will be screened. An initial search took place on 5 May 2019. The detailed search strategy can be found in the [online supplementary file a](#SP1){ref-type="supplementary-material"}. The search strategy will be presented in form of a PRISMA diagram ([figure 1](#F1){ref-type="fig"}).[@R23]
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![Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. CENTRAL, Cochrane Central Register of Controlled Trials.](bmjopen-2019-035413f01){#F1}

### Study records: data management, selection process and data collection process {#s2-2-1}

Two reviewers (PI and PK) will independently screen the references based on their titles and abstracts to identify studies that potentially meet the inclusion criteria. All potentially relevant references will be retrieved in full text and independently assessed by two reviewers (PI and PK). Any disagreements over eligibility will be resolved by consensus. Where necessary, a third review author (AM) will make a final judgement. Data from the full texts will be extracted and entered into a standardised form. The information to be extracted can be found in [table 2](#T2){ref-type="table"}.

###### 

Data that will be extracted from every study included in the review

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.     Description
  ------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       Authors and year of publication

  2       Country of study

  3       Type of study

  4       Study population

  5       Study completion rate

  6       Diagnosis

  7       Surgical approach: lateral/transgluteal (Hardinge/Bauer)[@R26]/anterolateral (Watson Jones) with or without trochanteric osteotomy[@R26]/anterior (Smith Petersen)[@R26]/posterior (Moore/ the southern exposure)[@R26]/minimally invasive anterolateral (Röttinger)[@R17]/anterior minimally invasive[@R26]/minimally invasive posterior (mini-posterior)[@R27]/2 incision (minimal invasive 2 incision)[@R28]/posterolateral[@R29]

  8\      Study population demographics\
  8a--f   Age, sex, height, body mass, body mass index, comorbidity index

  9\      Measurement methods\
  9a\     Isometric/isokinetic strength measurement\
  9b\     Angle of isometric measurement/speed of isokinetic measurement\
  9c      Patient position during the measurement (lying supine, lying lateral recumbent/standing)

  10      Comparators: healthy individuals/asymptomatic contralateral side/no comparator

  11      Total durations of follow-up (weeks after the operation)

  12      Measurement stages (preoperative, follow-up in weeks after the operation)

  13      Information regarding the rehabilitation protocols

  14\     Outcome (mean values, SDs and CIs)\
  14a\    Absolute values of hip abductor torque in patients after THA, or in asymptomatic control groups\
  14b\    Torque ratio (operated/contralateral hip) of hip abductors in patients after THA\
  14c\    Change in hip abductor torque/hip abductor torque ratio from baseline to the last available follow-up\
  14d     Differences in hip abductor torque/torque ratios between patients after THA and healthy control groups.

  15      Authors conclusions

  16      Information regarding risk of bias
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

THA, total hip arthroplasty.

Outcomes and prioritisation {#s2-3}
---------------------------

The main outcomes include:

1.  Absolute values of hip abductor torque in patients after THA, or in asymptomatic control groups.

2.  Torque ratio (operated/contralateral hip) of hip abductors in patients after unilateral THA.

3.  Change in hip abductor torque/hip abductor torque ratio from baseline to the last available follow-up.

4.  Differences in hip abductor torque/torque ratios between patients after THA and healthy control groups.

The secondary outcomes include:

1.  Surgical approaches/methods influencing the abductor muscle strength deficits after THA.

2.  Patient characteristics influencing the abductor muscle strength deficits after THA.

3.  Rehabilitation programmes influencing the abductor muscle strength deficits after THA.

4.  Study characteristics influencing the results.

Risk of bias in individual studies {#s2-4}
----------------------------------

The risk-of-bias assessment will be performed with a modified version of the Newcastle-Ottawa scale (NOS[@R24]; [online supplementary file b](#SP2){ref-type="supplementary-material"}) and conducted independently by two reviewers (PI and PK). According to the modified NOS, each study will be valued with 1--6 stars where higher scores indicate higher level of quality. No separate tool will be used to assess the risk of bias of randomised controlled trials (RCTs), since we do not extract estimates of treatment differences from RCTs but use them as a source for observational data.
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Data synthesis {#s2-5}
--------------

For any of the main outcomes, we will extract any information on the location (mean, median, etc) and any information on the population variation (SD, IQR, percentile) or on the precision of the location measure (standard errors, CIs, p values, sample size). If this information is available for several time points, the data will be extracted for all time points.

If results are given for specific patient subgroups, these results will be extracted together with the characteristics of the subgroup. The same applies for comparisons beyond those reflected by the main outcomes. In case that outcomes are not reported directly but indirect information is available on side-specific or time point-specific results, the available information will be transformed accordingly.

If several studies using the same type of measurement (isokinetic or isometric) at the same time period after THA and with the same comparator (asymptomatic contralateral side or group of asymptomatic control subjects) are available, we will pool the results for a meta-analysis.

All results will be presented in tabular format and forest plots. Whenever outcomes are not reported directly but only indirect information is available on side-specific or time point-specific results, the available information will be transformed accordingly.

Metaregression and subgroup-specific meta analyses will be used to investigate the influence of time since THA and type of measurement (isokinetic or isometric) on the different outcomes. In case of sufficient information, these analyses will be extended to include characteristics such as age, sex, surgical approach or rehabilitation programme.

Metabias(es) {#s2-6}
------------

To explore potential hints to publication bias or selective reporting, we will investigate the influence of all available study characteristics on the various outcomes.

Confidence in cumulative evidence {#s2-7}
---------------------------------

The strength of the body of evidence will be assessed with the Grading of Recommendations Assessment, Development and Evaluation system (GRADE).[@R25] GRADE is a method of assessing the certainty in evidence classifying it into one of the four categories: high, moderate, low and very low.[@R25]

Ethics and dissemination {#s3}
========================

This study is a protocol for a systematic review and meta-analysis. No human participants will be recruited. No ethics approval is needed. The results will be disseminated through peer-reviewed publications and conference presentations. All data relevant to the study are included in the article or uploaded as supplementary information.

Supplementary Material
======================
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